BioE's prequalified JE vaccine to be launched in endemic areas
This article was originally published in Scrip
Executive Summary
The Indian biopharmaceutical firm Biological E. (BioE) expects to commercialize its Japanese encephalitis vaccine - the first ever JE vaccine to be prequalified by the World Health Organization recently - in a clutch of endemic countries in the Asian region including Sri Lanka and Bangladesh.